3mon
Medpage Today on MSNRNA Interference Therapeutic Shows Promise for Chronic Hepatitis BPeginterferon alfa-2a is a form of recombinant interferon already indicated to treat chronic hepatitis B infection in people ...
Take with food in 2 divided doses, with peginterferon alfa-2a. ≥18yrs: Genotype 1, 4: (<75kg): 1g/day for 48 weeks; (≥75kg): 1.2g/day for 48 weeks. Genotype 2, 3: 800mg/day for 24 weeks.
Peginterferon alfa-2a, sold as Pegasys, is used to treat chronic hepatitis B and C as well as other blood diseases. Unexpectedly high demand for the medicine has led to shortages that the EMA said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results